HanS.H., LeeS.C., AhnS.V., LeeJ.E., ChoiH.Y., KimB.S.Improving outcome of CAPD: twenty-five years’ experience in a single Korean center.Perit Dial Int2007; 27: 432–40.
2.
Al WakeelJ.S., MitwalliA.H., TarifN., HammadD., Abu-AishaH., MemonN.Complications of CAPD: a single center experience.Saudi J Kidney Dis Transpl2005; 16: 29–32.
3.
KimD.K., YooT.H., RyuD.R., XuZ.G., KimH.J., ChoiK.H.Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade.Per it Dial Int2004; 24: 424–32.
4.
ZelenitskyS., BarnsL., FindlayI., AlfaM., ArianoR., FineA.Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998.Am J Kidney Dis2000; 36: 1009–13.
5.
SzetoC.C., LeungC.B., ChowK.M., KwanB.C., LawM.C., WangA.Y.Change in bacterial aetiology of peritoneal dialysis-related peritonitis over 10 years: experience from a centre in South-East Asia.Clin Microbiol Infect2005; 11: 837–9.
6.
TroidleL., Gorban-BrennanN., KligerA., FinkelsteinF.Differing outcomes of gram-positive and gram-negative peritonitis.Am J Kidney Dis1998; 32: 623–8.
7.
TranaeusA., HeimburgerO., GranqvistS.Diverticular disease of the colon: a risk factor for peritonitis in continuous peritoneal dialysis.Nephrol Dial Transplant1990; 5: 141–7.
8.
SingharetnamW., HolleyJ.L.Acute treatment of constipation may lead to transmural migration of bacteria resulting in gram-negative, polymicrobial, or fungal peritonitis.Perit Dial Int1996; 16: 423–5.
9.
RayS.M., PirainoB., HolleyJ.Peritonitis following colonoscopy in a peritoneal dialysis patient.Perit Dial Int1990; 10: 97–8.
10.
CaravacaF., Ruiz-CaleroR., DominguezC.Risk factors for developing peritonitis caused by micro-organisms of enteral origin in peritoneal dialysis patients.Perit Dial Int1998; 18: 41–5.
11.
del PesoG., BajoM.A., GadolaL., MillanI., CodoceoR., CeladillaO.Diverticular disease and treatment with gastric acid inhibitors do not predispose to peritonitis of enteric origin in peritoneal dialysis patients.Perit Dial Int2001; 21: 360–4.
12.
NessimS.J., TomlinsonG., BargmanJ.M., JassalS.V.Gastric acid suppression and the risk of enteric peritonitis in peritoneal dialysis patients.Perit Dial Int2008; 28: 246–51.
13.
KeaneW.F., SwanS.K., GrimesI., HumphriesT.J.Rabeprazole: pharmacokinetics and tolerability in patients with stable, end-stage renal failure.J Clin Pharmacol1999; 39: 927–33.
